Neuropsychological rehabilitation of memory deficits and activities of daily living in patients with Alzheimer's disease: A pilot study

Brazilian Journal of Medical and Biological Research

Volumn 37, Issue 11, 2004, Pages 1721-1729

  Ávila, Renata ^a,b   Bottino, C M C ^a   Carvalho, I A M ^a   Santos, C B ^a   Seral, C ^a   Miotto, E C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Alzheimer's disease treatment; Daily living activities; Memory; Neuropsychological rehabilitation

Indexed keywords

RIVASTIGMINE;

AGED; ALZHEIMER DISEASE; AMNESIA; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INTELLIGENCE QUOTIENT; MALE; MEMORY; MENTAL FUNCTION; MENTAL PERFORMANCE; MENTAL TASK; NEUROPSYCHOLOGICAL TEST; PSYCHOTHERAPY; QUALITY OF LIFE; RATING SCALE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE; TRAINING;

EID: 9244219684     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2004001100018     Document Type: Article

References (37)

1. Morris RG & Kopelman MD (1986). The memory deficits in Alzheimer-type dementia: A review. Quarterly Journal of Experimental Psychology, Special Issue: Human Memory, 38A: 575-602.
2. Clare L, Wilson BA, Carter G, Breen K, Gosses A & Hodges JR (2000). Intervening with everyday memory problems in dementia of Alzheimer type: an errorless learning approach. Journal of Clinical and Experimental Neuropsychology, 22: 132-146.
3. De Vreese LP, Ned M, Fioravanti M, Belloi L & Zanetti O (2001). Memory rehabilitation in Alzheimer's disease: a review of progress. International Journal of Geriatric Psychiatry, 16: 794-809.
4. Zanetti O, Binetti G, Magni E, Rozzini L, Bianchetti A & Trabucchi M (1997). Procedural memory stimulation in Alzheimer's disease: Impact of a training programme. Acta Neurologica Scandinavica, 95: 152-157.
5. Spector A, Orrell M, Davies S & Woods B (2000). Reminiscence therapy for dementia (Cochrane Review). In: The Cochrane Library. Issue 2. Update Software, Oxford, UK.
6. Spector A, Orrell M, Davies S & Woods B (2001). Reality orientation for dementia (Cochrane Review). In: The Cochrane Library Issue 4. Update Software, Oxford, UK.
7. McLellan DL (1991). Functional recovery and the principles of disability medicine. In: Swash M & Oxbury J (Editors), Clinical Neurology. Churchill Livingstone, London, UK.
8. Clare L & Woods B (2001). Editorial: A role for cognitive rehabilitation in dementia care. In: Clare L & Woods B (Editors), Cognitive Rehabilitation in Dementia. Psychology Press, London, UK.
9. Kitwood T (1991). Dementia Reconsidered: The Person Comes First. Open University Press, Buckingham, UK.
10. De Vreese LP, Iacono S, Finelli C, Gianelli MV & Neri M (1998). Enhancement of therapeutic effects of drug treatment in DAT when combined with cognitive retraining? A three month program. Neurobiology of Aging, 19(S4): 212-213.
11. Folstein NF, Folstein SE & McHugh PR (1975). Mini mental state: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12: 189-198.
12. Montgomery SA & Alsberg M (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134: 382-389.
13. Bruss GS, Gruenberg AM, Goldstein RD & Barber JP (1994). Hamilton Anxiety Rating Scale interview guide: joint interview and test-retest methods for interpreter reliability. Psychiatric Research 53: 191-202.
14. Tuenisse S & Derix MMA (1999). Interview to determine deterioration in daily functioning in dementia. Tijdscriff voor Gerontologite en Geriatric, 22: 53-59.
15. Sunderland A, Harris JE & Gleave J (1984). Memory failures in everyday life following severe head injury. Journal of Clinical Neuropsychology, 6: 127-142.
16. Novelli MMPC (2003). Adaptação transcultural da escala de avaliação de qualidade de vida na doença de Alzheimer. Master's thesis in Sciences, Experimental Fisiopathology Area, University of São Paulo, São Paulo, SP, Brazil.
17. Wechsler D (1987). Wechsler Memory Scale - Revised. The Psychological Corporation, New York.
18. Wechsler D (1981). Wechsler Intelligence Scale - Revised The Psychological Corporation, New York.
19. Fuld PA (1980). Guaranteed stimulus-processing in the evaluation of memory and learning. Cortex, 16: 255-272.
20. Warrington RK (1984). Recognitions Memory Test. NFER-Neison, Windsor, UK.
21. Goodglass H, Kaplan E & Barresi B (1998). The Assessment for Aphasia and Related Disorders. 3rd edn. Lippincott Williams & Wilkins, Baltimore, MD, USA.
22. Spreen A & Strauss E (1998). A Compendium of Neuropsychological Tests - Administration, Norms and Commentary. 2nd edn. Oxford University, NewYork.
23. Brucki SM, Malheiros SM, Okamoto IH & Bertoluoci PH (1997). Normative data on verbal fluency test in the animal category in our milieu. Arquivos de Neuro-Psiquiatria, 55: 56-61 (Portuguese).
24. Spreen A & Benton AL (1969). Neurosensory Center Comprehensive Examination for Aphasia (NCCEA). University of Victoria Neuropsychology Laboratory, Victoria.
25. Goldstein G & Beers S (1988). Assessment and planning for memory retraining. In: Goldstein G & Beers S (Editors), Rehabilitation Plenum, New York.
26. Squire LR & Kandel ER (1999). Memory - From Mind to Molecules. Scientific American Library, New York.
27. Baddeley AD & Wilson BA (1994). When implicit learning fails: amnesia and the problem of error elimination. Neuropsychologia, 32: 53-68.
28. Ready RE, Ott BR & Grace J (2004). Patient versus informant perspectives of quality of life in mild cognitive impairment and Alzheimer's disease. International Journal of Geriatric Psychiatry, 19: 256-265.
29. Rockwood K, Joyce B & Stolee P (1997). Use of goal attainment scaling in measuring clinically important change in cognitive rehabilitation patients. Journal of Clinical Epidemiology, 50: 581-588.
30. Rösler M, Anand R, Cicin-Sain A, Gauthier S, Agid Y, Dal-Bianco P, Stähelin HB, Hartman R & Gharabawi M (1999). Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomized controlled trial. British Medical Journal, 318: 633-640.
31. Farlow M, Potkin S, Koumaras B, Veach J & Mirski D (2003). Analysis of outcome in retrieved dropout patients in a Rivastigmine vs placebo, 26 weeks, Alzheimer disease trial. Archives of Neurology, 60: 843-848.
32. Davis RN, Massman PJ & Doody RS (2001). Cognitive intervention in Alzheimer disease: a randomized placebo-controlled study. Alzheimer Disease and Associated Disorders, 15: 1-9.
33. Heiss WD, Kessler J, Mielke R, Szelies B & Herholz K (1994). Long-term effects of phosphatidylserine, pyritinol and cognitive training in Alzheimer's disease. A neuropsychological, EEG, and PET investigation. Dementia, 5: 88-98.
34. Camp CJ & McKitrick LA (1992). Memory intervention in Alzheimer's type dementia populations: methodological and theoretical issues. In: West RL & Sinnot JD (Editors), Everyday Memory and Ageing: Current Research and Methodology. Spring-Verlag, New York.
35. Bottino CMC, Carvalho IAM, Alvarez AMM, Ávila R, Zukauskas PR, Bustamante SEZ, Andrade FC, Hototian SR, Saffi F & Camargo CHP (2002). Cognitive rehabilitation in Alzheimer's disease patients: multidisciplinary team report. Arquivos de Neuro-Psiquiatria, 60: 70-79.
36. Farina E, Fioravanti R, Chavari L, Imbornone E, Alberoni M, Pomati G, Pignatti R & Marinari C (2002). Comparing two programs of cognitive training in Alzheimer's disease: a pilot study. Acta Neurologica Scandinavica, 105: 365-371.
37. Baddeley A (2001). Treating memory problems. In: Baddeley A (Editor), Human Memory. Psychology Press, London, UK.